TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11384572

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9223203

Group type: COMPARATOR
Intervention: Continuous infusion of 0.25% bupivacaine (group C, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intermittent hourly bolus of 0.25% bupivacaine (group B, n = 10)
Number of subjects: 20
Study: 8124207

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg bd)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 92
Study: 3303813

Group type: EXPERIMENTAL
Intervention: Oxytocin (up to 30 mIU/min)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose prostaglandin F2 alpha (PGF2 alpha, up to 6.0 micrograms/min)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Low-dose prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 100
Study: 2809851

Group type: EXPERIMENTAL
Intervention: Ceramic crown systems (Cerestore, Dicor, Hi‐Ceram, Renaissance, Vitadur‐N)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Coloured luting agents
Number of subjects: 25
Study: 31801600

Group type: EXPERIMENTAL
Intervention: Fire acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: General acupuncture
Number of subjects: 120
Study: 27028190

Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg plus solifenacin 5 mg (Group II)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg plus solifenacin 10 mg (Group III)
Number of subjects: 146

Group type: COMPARATOR
Intervention: tamsulosin 0.2 mg (Group I)
Number of subjects: 146
Study: 26075840

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 1432

Group type: EXPERIMENTAL
Intervention: Perphenazine (first-generation antipsychotic)
Number of subjects: 1432
Study: 23805979

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 3 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-trained CHF patients (CHF-C group)
Number of subjects: 21
Study: 20953959

Group type: EXPERIMENTAL
Intervention: Intracoronary BMC
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 19221919

Group type: EXPERIMENTAL
Intervention: Therapist-guided web-based cognitive behavioural treatment (web-CBT)
Number of subjects: 54
Study: 16916668

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (4 microg.kg(‐1).h(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Midazolam (0.4 mg.kg(‐1).h(‐1))
Number of subjects: 20
Study: 15770968

Group type: EXPERIMENTAL
Intervention: Posterior dynamic imaging
Number of subjects: 68

Group type: COMPARATOR
Intervention: Anterior dynamic imaging
Number of subjects: 68
Study: 11294076

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions
Number of subjects: 0
Study: 9610217

Group type: EXPERIMENTAL
Intervention: Generic outcome - Life satisfaction
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Generic health
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Incontinence-specific QoL outcomes
Number of subjects: 435
Study: 7936339

Group type: EXPERIMENTAL
Intervention: Dopexamine infusion at a dose of 1 microgram/kg/m during aortic cross-clamping and 0.5 micrograms/kg/m from declamping to the end of surgery
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dopexamine infusion
Number of subjects: 25

Group type: COMPARATOR
Intervention: No dopexamine infusion (Control Group I)
Number of subjects: 25
Study: 3354934

Group type: EXPERIMENTAL
Intervention: Automatic external defibrillators used to defibrillate and record patient rhythms
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group with automatic external defibrillators used only to record
Number of subjects: 36
Study: 29998356

Group type: EXPERIMENTAL
Intervention: Laser therapy applied on the right side
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo applied on the right side
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Laser therapy applied on the left side
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo applied on the left side
Number of subjects: 62

Group type: COMPARATOR
Intervention: Gender comparison in placebo group
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Gender comparison in laser group after 48 hours
Number of subjects: 62
Study: 28851276

Group type: EXPERIMENTAL
Intervention: Horticultural therapy (HT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 70
Study: 25358119

Group type: EXPERIMENTAL
Intervention: Internet support intervention
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 414
Study: 22372531

Group type: EXPERIMENTAL
Intervention: Prasugrel (30 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg)
Number of subjects: 21
Study: 21171738

Group type: EXPERIMENTAL
Intervention: Self-Motivational (SM) orientation + Parent-Child Interaction Therapy (PCIT)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Self-Motivational (SM) orientation
Number of subjects: 192

Group type: COMPARATOR
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Services as Usual (SAU)
Number of subjects: 192
Study: 19894381

Group type: EXPERIMENTAL
Intervention: SXDZ-100 Nerve and Muscle Stimulator
Number of subjects: 87

Group type: COMPARATOR
Intervention: G6805 Electric Stimulator
Number of subjects: 87
Study: 18386606

Group type: EXPERIMENTAL
Intervention: Trimebutine 100 mg t.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo t.i.d.
Number of subjects: 50
Study: 12492804

Group type: EXPERIMENTAL
Intervention: Clonidine 4 micro g kg‐1 in apple juice 0.2 ml kg‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Apple juice 0.2 ml kg‐1 (Control)
Number of subjects: 80
Study: 11270321

Group type: EXPERIMENTAL
Intervention: (‐)‐R‐clevidipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: (+)‐S‐clevidipine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Racemic clevidipine
Number of subjects: 20
Study: 9594559

Group type: EXPERIMENTAL
Intervention: Patients with CAD or HT
Number of subjects: 148

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Diastolic dysfunction ratio (DDR)
Number of subjects: 148
Study: 8319552

Group type: EXPERIMENTAL
Intervention: Single 1-s vibroacoustic stimulus (VAS) delivered after 3-5 min of quiet sleep (QS), Group II, N = 33
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Single 1-s vibroacoustic stimulus (VAS) delivered after 18-20 min of quiet sleep (QS), Group III, N = 31
Number of subjects: 96

Group type: COMPARATOR
Intervention: No stimulation, Group I, N = 32
Number of subjects: 96
Study: 2967184

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg once daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg once daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: All treatments (Bisoprolol 5 mg, Bisoprolol 10 mg, Atenolol 100 mg)
Number of subjects: 19
Study: 29957829

Group type: EXPERIMENTAL
Intervention: Diet alone
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diet + resistance training
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diet + aerobic training
Number of subjects: 140
Study: 27410392

Group type: EXPERIMENTAL
Intervention: Individualised nutritional care by a dietitian, including prescription of wound healing supplements
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard nutritional care
Number of subjects: 50
Study: 25414095

Group type: EXPERIMENTAL
Intervention: Books Beyond Words booklet plus usual care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine information and services (control group)
Number of subjects: 40
Study: 22322195

Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) training (four, 2‐min sustained contractions at 30% of maximal voluntary contraction, three times per week for 8‐10 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (medicated hypertensive patients)
Number of subjects: 20
Study: 19800680

Group type: EXPERIMENTAL
Intervention: T suis ova (2500 live ova, 8 doses, 21-day interval)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: T suis ova
Number of subjects: 100
Study: 17273038

Group type: EXPERIMENTAL
Intervention: Focal-dome osteotomy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Straight-cut osteotomy
Number of subjects: 27
Study: 16143578

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask in right lateral position
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask in left lateral position
Number of subjects: 82

Group type: COMPARATOR
Intervention: Intubating laryngeal mask
Number of subjects: 82
Study: 12172716

Group type: EXPERIMENTAL
Intervention: Group I: 50-ml mixture of 20 ml 0.5% bupivacaine hydrochloride, 10 ml 2% lidocaine hydrochloride, and 20 ml 0.9% sodium chloride; knee joint injected with 40 ml of the mixture; portal sites injected with 10 ml of the mixture.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group II: Same mixture as Group I with 250 micro g epinephrine added; knee joint injected with 40 ml of the mixture; portal sites injected with 10 ml of the mixture.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group III: Same mixture as Group I with 50 micro g epinephrine added to 10 ml of the mixture for portal site injections; knee joint injected with 40 ml of the mixture.
Number of subjects: 130
Study: 9526147

Group type: EXPERIMENTAL
Intervention: Expectancy challenge targeting arousal
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Expectancy challenge targeting sociability
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 54
Study: 8578174

Group type: EXPERIMENTAL
Intervention: High dose of recombinant interferon-alpha-2b (3 MIU, 3/7 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Low dose of recombinant interferon-alpha-2b (1 MIU, 3/7 days)
Number of subjects: 74
Study: 2533669

Group type: EXPERIMENTAL
Intervention: Oestrogen‐progestogen combinations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pure progestagen
Number of subjects: 0
Study: 347229

Group type: EXPERIMENTAL
Intervention: Sustained-release procainamide (PAD)
Number of subjects: 7
Study: 30599885

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 20
Study: 27910283

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1546

Group type: COMPARATOR
Intervention: Corn-soy blends (CSB)
Number of subjects: 1546
Study: 27092789

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg once a day for 12 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once a day for 12 weeks
Number of subjects: 80
Study: 24687847

Group type: EXPERIMENTAL
Intervention: Tailored education-coaching intervention
Number of subjects: 135

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 135
Study: 22288493

Group type: EXPERIMENTAL
Intervention: Daily reports tapping experienced or experienced and witnessed negative events
Number of subjects: 215

Group type: COMPARATOR
Intervention: No daily reports
Number of subjects: 215
Study: 19844656

Group type: COMPARATOR
Intervention: Disc arthroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spinal fusion
Number of subjects: 0
Study: 18448748

Group type: EXPERIMENTAL
Intervention: Increasing maximal vaginal descent
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Increasing apical descent (POP-Q point C)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Increasing anterior descent (POP-Q point Ba)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Increasing posterior descent (POP-Q point Bp)
Number of subjects: 260
Study: 16128472

Group type: EXPERIMENTAL
Intervention: Four firefighter extraction team with accompanying nurse and respiratory therapist
Number of subjects: 12

Group type: COMPARATOR
Intervention: Four member teams
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Three member teams
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Firefighters' subjective evaluation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall performance evaluations
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mean extraction time
Number of subjects: 12
Study: 11753127

Group type: EXPERIMENTAL
Intervention: Minimally invasive therapies using thermal energy to ablate prostatic tissue
Number of subjects: 0
Study: 9990599

Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5534 and 5034)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5524 and 5024)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5534)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5524)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: High impedance steroid‐eluting pacing leads (Medtronic model 5034)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Standard steroid‐eluting pacing leads (Medtronic model 5024)
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: High impedance leads
Number of subjects: 609
Study: 7579565

Group type: EXPERIMENTAL
Intervention: Cisplatin 20 mg/m2 in 15 min i.v. infusion followed by FA 500 mg/m2 in 1 h i.v. infusion, with 5-FU 500 mg/m2 i.v. bolus administered in the middle, repeated weekly for 4 weeks followed by a 2 week rest, for a maximum of six cycles.
Number of subjects: 30
Study: 1377769

Group type: EXPERIMENTAL
Intervention: Synthetic substance P (SP) at doses of 0.5, 1.0, or 1.5 pmol/kg‐1/min‐1 for 60 minutes
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 7
Study: 6373161

Group type: EXPERIMENTAL
Intervention: Clomipramine (25 to 150 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Diazepam (10 to 30 mg)
Number of subjects: 33
Study: 31404538

Group type: EXPERIMENTAL
Intervention: My Birth Control (intervention)
Number of subjects: 15
Study: 30367647

Group type: EXPERIMENTAL
Intervention: PMX‐HP
Number of subjects: 59

Group type: COMPARATOR
Intervention: non‐PMX‐HP
Number of subjects: 59

Group type: COMPARATOR
Intervention: PMX‐HP and non‐PMX‐HP
Number of subjects: 59
Study: 27605966

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Resisted exercise training for 12 weeks
Number of subjects: 100
Study: 24590257

Group type: EXPERIMENTAL
Intervention: Long-term antidepressant medication
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Continuing antipsychotic medication
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: No further antidepressant treatment
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Multiple hospitalizations
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Avoidant personality disorder
Number of subjects: 458
Study: 23681396

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Atorvastatin and Placebo
Number of subjects: 200
Study: 21855742

Group type: EXPERIMENTAL
Intervention: Exercise intervention (12-month duration)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Self-regulatory strategies and executive function
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Percentage of exercise classes attended
Number of subjects: 177
Study: 19282169

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (morning dosing)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (evening dosing)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5mg/day (both morning and evening dosing)
Number of subjects: 60
Study: 17908580

Group type: EXPERIMENTAL
Intervention: 2/100Hz alternating frequency TENS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 100Hz TENS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 2Hz TENS
Number of subjects: 64

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 64
Study: 15281507

Group type: EXPERIMENTAL
Intervention: Multimodal group (TIVA with propofol, droperidol, and ondansetron)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combination group (droperidol and ondansetron with isoflurane and nitrous oxide)
Number of subjects: 90

Group type: COMPARATOR
Intervention: TIVA group (propofol for induction and maintenance)
Number of subjects: 90
Study: 11525372

Group type: EXPERIMENTAL
Intervention: Laparoscopic preperitoneal 'bikini mesh' hernia repair (TAPP)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Open Lichtenstein hernioplasty
Number of subjects: 43
Study: 9603532

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg daily)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study: 7549773

Group type: EXPERIMENTAL
Intervention: Loss of control and inability to abstain measures
Number of subjects: 97
Study: 2180861

Group type: EXPERIMENTAL
Intervention: Relaxation technique (slow, deep-breathing)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no relaxation training)
Number of subjects: 29
Study: 7406249

Group type: EXPERIMENTAL
Intervention: Oral prednisone 2 mg/kg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30823922

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 7

Group type: COMPARATOR
Intervention: Palm oil
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 28350928

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 760
Study: 26359031

Group type: EXPERIMENTAL
Intervention: Current use of meloxicam
Number of subjects: 6780

Group type: EXPERIMENTAL
Intervention: Late use of meloxicam
Number of subjects: 6780

Group type: COMPARATOR
Intervention: Never used meloxicam
Number of subjects: 6780
Study: 23799528

Group type: EXPERIMENTAL
Intervention: Risperidone treatment
Number of subjects: 225
Study: 21350199

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (alteplase)
Number of subjects: 1699

Group type: COMPARATOR
Intervention: Non-thrombolyzed comparators
Number of subjects: 1699
Study: 19186729

Group type: EXPERIMENTAL
Intervention: Salt-moxibustion group
Number of subjects: 86

Group type: COMPARATOR
Intervention: Electroacupuncture group
Number of subjects: 86
Study: 17263767

Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg) during hypoglycaemia (2.8 mmol/l for 65 min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo during hypoglycaemia (2.8 mmol/l for 65 min)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg) during euglycaemia
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo during euglycaemia
Number of subjects: 17
Study: 15093870

Group type: EXPERIMENTAL
Intervention: Ranolazine 500 mg twice daily
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ranolazine 1000 mg twice daily
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ranolazine 1500 mg twice daily
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ranolazine (all doses)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 191
Study: 11208222

Group type: EXPERIMENTAL
Intervention: Vectored upper cervical (atlas) adjustment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Resting control
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Postrest to postadjustment readings
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre/post drop in systolic pressure
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pre/postrest change in systolic blood pressure
Number of subjects: 80
Study: 9274262

Group type: EXPERIMENTAL
Intervention: New polyurethane foam dressing
Number of subjects: 61

Group type: COMPARATOR
Intervention: Hydrocellular dressing
Number of subjects: 61
Study: 8173750

Group type: EXPERIMENTAL
Intervention: Gas-exchange method (VO2GE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fick method (VO2F)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thermodilution with iced saline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Thermodilution with room temperature saline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Thermodilution with room temperature saline (end expiration)
Number of subjects: 10
Study: 2311729

Group type: EXPERIMENTAL
Intervention: Education at asthma school
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no education at asthma school)
Number of subjects: 40
Study: 254058

Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection with femur internally rotated (narcotic medication)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dorsogluteal injection with femur externally rotated (narcotic medication)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection with femur internally rotated (diazepam)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dorsogluteal injection with femur externally rotated (diazepam)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dorsogluteal injection (diazepam)
Number of subjects: 44
Study: 31232909

Group type: EXPERIMENTAL
Intervention: Active rTMS (n = 8)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham rTMS (n = 6)
Number of subjects: 15
Study: 31403814

Group type: EXPERIMENTAL
Intervention: Body Project Treatment (BPT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study: 28264631

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: McConnell taping
Number of subjects: 14

Group type: COMPARATOR
Intervention: No tape
Number of subjects: 14
Study: 25677380

Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg kg(‐1) orally once every other day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38